US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 2.4350
  • +0.0150+0.62%
Trading May 2 10:24 ET
455.39MMarket Cap-2536P/E (TTM)

Taysha Gene Therapies Key Stats

Taysha Gene Therapies Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 19, 2024

Revenue(YoY)

3.60M

+44.04%
EPS(YoY)

0.26

+125.79%

Strong Buy

Apr 30, 2024

Taysha Gene Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.310M--
--2024/Q1-- / 2.305M--
Mar 19, 20242023/Q43.604M / 2.655M--
Nov 14, 20232023/Q34.746M / 2.099M--
Aug 14, 20232023/Q22.395M / 1.863M--
May 11, 20232023/Q14.706M / 1.125M--
Mar 28, 20232022/Q42.502M / 9.000M--
Nov 8, 20222022/Q30.000 / 0.000--
Aug 11, 20222022/Q20.000 / 0.000--
May 16, 20222022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.310M--
--2024/Q1-- / 2.305M--
Mar 19, 20242023/Q43.604M / 2.655M--
Nov 14, 20232023/Q34.746M / 2.099M--
Aug 14, 20232023/Q22.395M / 1.863M--
May 11, 20232023/Q14.706M / 1.125M--
Mar 28, 20232022/Q42.502M / 9.000M--
Nov 8, 20222022/Q30.000 / 0.000--
Aug 11, 20222022/Q20.000 / 0.000--
May 16, 20222022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Taysha Gene Therapies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg